mRNAs are nanoscale machines. They are programmed and injected.
ANA MARIA MIHALCEA, MD, PHD published today this important video of Ian F. Akyildiz "COVID MRNAS ARE NOTHING MORE THAN SMALL SCALE BIO-NANO MACHINES"
https://anamihalceamdphd.substack.com/p/covid-mrnas-are-nothing-more-than
The same video on Rumble:
https://rumble.com/v2gs5yo-dr.-ian-akyildiz-injecting-programmable-mrna-bio-nano-scale-machines.html
THIS IS EXACTLY THE TECHNOLOGY THAT IS INJECTED, PROGRAMMED AND MANIPULATED.
THIS IS THE REASON FOR TOXICITY, INJURY AND DEATH.
STOP THE GENOCIDE NOW.
https://ianakyildiz.com/about/
In this video Ian F. Akyildiz says:
“And then here Internet of BioNano Things - this are for the health applications. I did also research on that for the last 15 years; Bio nano scale machines, but these are for the injecting into the body and always monitoring the health problems.
And that is also going really well with these Covid vaccines. It’s going that direction. These mRNAs are nothing than small scale nanoscale machines. They are programed and they are injected.
And then Internet of Nano scale Things.
Those would be a part of 7 G and beyond.”
THAT'S EXACTLY WHAT WE WERE TRYING TO TELL EVERYONE!
He also says: “Oh, what we did is following - I have to share with you:
These surfaces, when we used metamaterials, they work very well for the lower spectrums. For higher spectrums, we used graphene. Just keep this in mind. When you use metamaterials for the higher surfaces, they don’t perform well. So you have to use graphene to get the best performance, right?
WHO IS THIS GUY?
About Dr. Akyildiz
Dr. Ian F. Akyildiz (Life Fellow, IEEE) received BS, MS, and PhD degrees in Electrical and Computer Engineering from the University of Erlangen-Nurnberg, Germany, in 1978, 1981, and 1984, respectively. He is also Founder and President of the Truva Inc., a consulting company based in Georgia, USA, since 1989. He is an Advisory Board member at the Technology Innovation Institute (TII) Abu Dhabi, United Arab Emirates, since June 2020. He is the Founder and the Editor-in-Chief of the newly established of International Telecommunication Union Journal on Future and Evolving Technologies (ITU J-FET) since August 2020.
He served as the Ken Byers Chair Professor in Telecommunications, the Past Chair of the Telecom Group at the ECE, and the Director of the Broadband Wireless Networking Laboratory, Georgia Institute of Technology, from 1985 to 2020.
Dr. Akyildiz has had many international affiliations during his career and established research centers in Spain, South Africa, Finland, Saudi Arabia, Germany, Russia, India, and Cyprus. Dr. Akyildiz is an IEEE Fellow since 1996, and ACM Fellow since 1997. He received numerous awards from IEEE, ACM, and other professional organizations, including Humboldt Award from Germany and Tubitak Award from Turkey.
In March 2022, according to Google Scholar his h-index is 132 and the total number of citations to his articles is more than 133+K. His current research interests include 6G/7G wireless systems, Terahertz Communication, Hologram communication, Extended Reality Wireless Communication, reconfigurable intelligent surfaces, Internet of Space Things/CUBESATs, Internet of Bio-Nano Things, molecular communication, and underwater and underground communication.
Some of his works:
http://web.archive.org/web/20200605012726/http://bwn.ece.gatech.edu/papers/2015/j3.pdf THE INTERNET OF BIO-NANOTHINGS
The properties of recently studied nanomaterials, such as graphene, have inspired the concept of Internet of NanoThings (IoNT), based on the interconnection of nanoscale devices. Despite being an enabler for many applications, the artificial nature of IoNT devices can be detrimental where the deployment of NanoThings could result in unwanted effects on health or pollution.
While nanothings can push the engineering of devices and systems to unprecedented environments and scales, similarly to other devices, they have an artificial nature, since they are based on synthesized materials, electronic circuits, and interact through electromagnetic (EM) communications [1]. These characteristics can be detrimental for some application environments, such as inside the body or in natural ecosystems, where the deployment of nanothings and their EM radiation could result in unwanted effects on health or pollution. A novel research direction in the engineering of nanoscale devices and systems is being pursued in the field of biology, by combining nanotechnology with tools from synthetic biology to control, reuse, modify, and reengineer biological cells [2]. By stemming from an analogy between a biological cell and a typical IoT embedded computing device, a cell can be effectively utilized as a substrate to realize a so-called BioNanoThing, through the control, reuse, and reengineering of biological cells’ functionalities, such as sensing, actuation, processing, and communication. Since cells are based on biological molecules and biochemical reactions, rather than electronics, the concept of Internet of Bio-NanoThing (IoBNT), introduced in this article, is expected to be paradigm shifting for many related disciplines, such as communication and network engineering, which is the focus of this article. The execution of DNA-based instructions, the biochemical processing of data, the transformation of chemical energy, and the exchange of information through the transmission and reception of molecules, termed molecular communication (MC) [3], are at the basis of a plethora of applications that will be enabled by the IoBNT, such as: • Intra-body sensing and actuation, where Bio-NanoThings inside the human body would collaboratively collect health-related information, transmit it to an external healthcare provider through the Internet, and execute commands from the same provider such as synthesis and release of drugs. • Intra-body connectivity control, where BioNanoThings would repair or prevent fail ures in the communications between our internal organs, such as those based on the endocrine and the nervous systems, which are at the basis of many diseases. • Environmental control and cleaning, where Bio-NanoThings deployed in the environment, such as a natural ecosystem, would check for toxic and pollutant agents, and collaboratively transform these agents through bioremediation, e.g. bacteria employed to clean oil spills.
ENABLING TECHNOLOGIES AND CHALLENGES The discipline of synthetic biology is providing tools to control, reuse, modify, and reengineer the cells’ structure and function, and it is expected to enable engineers to effectively use the biological cells as programmable substrates to realize Bio-NanoThings as biological embedded computing devices [2]. DNA sequencing and synthesis technologies, enabling the reading and writing of genetic code information in the DNA molecules of biological cells, are giving engineers an increasingly open access to the set of structural and functional instructions at the basis of life. In particular, the engineering of synthetic biological circuits [5] through genetic code manipulation has enabled the programming of specifically designed functions to be executed by cells. A biological circuit is a set of genes that encode proteins and regulatory sequences, which link together the protein synthesis by mechanisms of mutual activation and repression. The functions today successfully developed via biological circuits range from AND and OR logic gates, to various types of tunable oscillators, toggle switches, and counters. The development of databases with characterized standard biological circuit parts with known functions and behaviors, e.g. BioBricks, and tools to combine them into more complex designs [6], are pushing synthetic biology to a future development similar to that experienced by integrated electrical circuit design in electronics. As a consequence, engineers will be soon able to gain full access to the functionalities of the aforementioned cells’ elements, and reuse cells and their features, without requiring an in-depth knowledge of biotechnology.
One of the latest frontiers in synthetic biology is the development of artificial cells, enabled, among others, by tools from nanotechnology. Artificial cells have minimal functionalities and structural components compared to natural cells, and are assembled bottom-up by encapsulating the necessary elements into either biological or fully synthetic enclosing membranes [7]. Artificial cells can therefore contain genetic information, the related molecular machineries for their transcription, translation, and replication, and all the required specialized molecules and structures. Artificial cells are expected to enable a more agile and controllable use of synthetic biological circuits by removing all the additional complexity of natural cells that are not necessary to perform the designed functions. Although still in its infancy, this technology has been successfully applied, e.g. for drug delivery, gene therapy, and artificial blood cell production, and it is expected to deliver ideal substrates for synthetic biology with a more predictable behavior.
Another challenge that needs to be considered is related to bioethics and security, since autonomously evolving engineered organisms could pose a threat to the natural ecosystems, and even become new pathogens. The recent development of “kill” switches into biological circuits, able to stop cell reproduction or trigger cell destruction upon an external command, is only partially addressing these problems.
Researchers at Georgia Tech have drawn up blueprints for a wireless antenna made from atom-thin sheets of carbon, or graphene, that could allow terabit-per-second transfer speeds at short ranges.
“It’s a gigantic volume of bandwidth. Nowadays, if you try to copy everything from one computer to another wirelessly, it takes hours. If you have this, you can do everything in one second—boom,” says Ian Akyildiz, director of the broadband wireless networking laboratory at Georgia Tech.
To make an antenna, the group says, graphene could be shaped into narrow strips of between 10 and 100 nanometers wide and one micrometer long, allowing it to transmit and receive at the terahertz frequency, which roughly corresponds to those size scales. Electromagnetic waves in the terahertz frequency would then interact with plasmonic waves—oscillations of electrons at the surface of the graphene strip—to send and receive information.
“Antennas made of graphene can be made much smaller in all dimensions than a metal wire antenna. It can be made to be on the order of a micrometer or a few nanometers,” Avouris says. “The significance is that the antenna can be incorporated in a very small object.”
http://web.archive.org/web/20170709065752/http://bwn.ece.gatech.edu/patents/UM-MIMO-THz.pdf
https://daneshyari.com/article/preview/6882905.pdf 5G roadmap: 10 key enabling technologies
Artificially developed cells that are injected into the body and who monitor and wipe out all disease. That is the dream of the American researcher Ian Akyildiz. - The artificial cells may circulate in the blood system and be an addition to the red and white blood cells. They will be programmed to detect viruses, bacteria, and tumors and attacking all diseases, such as Alzheimer's disease, diabetes, cancer and influenza, Akyildiz says. He is Professor of Electrical and Computer Engineering at the Georgia Institute of Technology Atlanta, USA, and one of the key note speakers at the VERDIKT conference 2013. About ten years ago he became interested in nano networks when he began to wonder how nanoscale devices could be used for transmitting and receiving information. Most components in nanoscale devices available today are millions of times smaller than an ant and primitive with limited options. - However, if the different machines begin to communicate, they can collaborate and share information. Thus the uses powerful, Akyildiz says. Bacteria show the way While researchers are actively working on the development of artificial cells, which are made of artificial nanomaterials and mimic the way cells work and interact with each other in the nature, an alternative viable way to realize the aforementioned objectives is to genetically program biological cells to perform specific functions. On the one hand, the development of artificial cells faces numerious challenges: How to get the artificial cells to communicate? How to get them to understand when they encounter a problem that must be solved? And not least - how to get the body to accept the artificial cells? On the other hand, the use of genetically programmed biological cells takes advantage of the solutions that nature already provided to most of these issues. Scientists worlwide are today trying to develop nanomaterial-based components suitable for artificial cells, but Akyildiz is aware that the process will take a long time, perhaps 20 years or longer. At the same time, recent advancements of the research on genetically programmed biological cells have increased the belief that the realization of the aforementioned goals is not just science fiction. Akyildiz and his collaborators are also actively involved in this latter research direction, and in particular they focus on the engineering of communication pathways between genetically engineered bacteria. Bacteria are among the simplest cellular organisms, and since the techniques to realize their genetic programming are quite well established, they are easier to study. - The research on communication among genetically engineered bacteria has been a great success. During the first three years of the MoNaCo (Fundamentals of Molecular NanoCommunication Networks) project, supported by the US National Science Foundation (NSF), has been going on so far, they have learned a lot about how genetically engineered bacteria can share information and form networks to coordinate their behavior. These natural solutions can probably be used to develop communication models for different nanonetworks, as for instance the future artificial cells, Akyildiz says. More targeted drug delivery The communication technique used by bacteria is called molecular communication, where bacteria exchange information-bearing molecules between each other. While Akyildiz and his collaborators are building tools to realize network of bacteria based on this communication technique, they also apply these same tools to study targeted drug delivery systems within a project supported by the Samsung Advanced Institute of Technology (SAIT). The goal is to help medicine direct drug particles to the exact spot where it is needed, while minimizing the effects on other healthy parts of the body - and make sure that the medication has the correct concentration when it arrives at the targeted spot. There are for instance great differences in how individuals react to drugs. These differences can have dramatic effects on the impact of specific doses subministered to each individual. - More targeted drug delivery may lead to fewer deaths from adverse drug use, and more effective treatment of the disease, Akyildiz says. To get there, researchers must understand how the drug particles, which can have a nanoscale size, are dissolved and distributed in the body over time. These are among the questions Akyildiz and his colleagues address through the study of molecular communication, by drawing an analogy between how bacteria communicate and how drug particles are propagated and absorbed in a human body. - Targeted drug delivery and artificial blood cells are just two of the many areas within medicine and health where nanotechnology could prove to be very useful. At best we can contribute to a medical revolution, Akyildiz says
https://ieeexplore.ieee.org/abstract/document/7029669 Genetically Engineered Bacteria-Based BioTransceivers for Molecular Communication | IEEE Journals & Magazine | IEEE Xplore
A bacteria can be programmed as a biotransceiver by modifying their genetic code to implement biological circuits.
https://ieeexplore.ieee.org/abstract/document/6708549
The results show that, by exploiting the high mode compression factor of SPP waves in GNRs, graphene-based plasmonic nano-antennas are able to operate at much lower frequencies than their metallic counterparts
https://ianakyildiz.com/bwn/media.html
https://scholar.google.com/citations?user=rAGwv14AAAAJ
https://ieeexplore.ieee.org/abstract/document/9149878
Therefore, BNTs can detect the infection of P. aeruginosa in 1.5-2 hours after the start of infection. Compared to 16-24 hours required for the culture of P. aeruginosa for lab test. Our proposed framework can detect infections earlier than lab tests. The detection time of 1.5-2 hours found for this scenario may vary according to infected tissue structure, the distance of BNTs to the infection site, and diffusion properties of QS molecules, and may be higher or lower for different systems. However, by utilizing the various detection techniques devised for molecular communication in the literature, it is possible to improve the detection times. Another improvement might come from the compensation of interpersonal variations since every patients body is unique. Hence, a calibration of the sensors at the time of deployment can be also used to improve the detection efficiency and speed paving the way for personalized medicine…
https://ieeexplore.ieee.org/abstract/document/8710366 Moving forward with molecular communication: from theory to human health applications [point of view] | IEEE Journals & Magazine | IEEE Xplore
The E. coli bacteria are synthetically engineered to encode components of QS from the bacterium Vibrio fischeri (V. fischeri). As illustrated in Fig. 3(a), the bacteria within the transmitter compartment upon excitation will release molecules that flow along the microchannel toward another population of bacteria representing the receiver. At the receiver, the E. coli bacteria are engineered with DNA from the V. fischeri, which enables them to fluoresce once the autoinducer molecules arrive with a certain concentration. This fluorescing of the bacteria indicates a successful communication process through the microchannel.
D. Hydrogel-Based Chemo-Electro Signal Transduction Device
A further interface between the electrical and molecular domains is being studied through a redox-based experimental platform [15], as illustrated in Fig. 3(d), with reference to the MC research direction introduced in Section III-B2. This wet-lab interface device prototype is composed of a dual-film coating where the outer film is a hydrogel entrapping genetically engineered E. coli cells, and the inner film is a redox capacitor that amplifies the detection of redox-active molecules at the gold electrode. These cells are engineered as reporters, which respond to the presence of a certain molecule (signaling molecule AI-2) by converting the redox-inactive substrate 4-Aminophenyl β -D-galactopyranoside (PAPG) molecules into redox-active p-aminophenol (PAP). Research has begun investigating this technology to create a novel generation of bioelectronic components that will serve as the basis of the intelligent drugs, capable of biochemical and electrical computation and actuation.
While a number of different experimental platforms have been developed to validate and demonstrate the theory of MC, there are still numerous opportunities still available with existing technologies that have been developed in the field of biotechnology. A good example is the organ-on-a-chip that allows cell culture of an organ to be grown on a microfluidic device, simulating the internal physiological activities. This has also been extended toward human-on-a-chip, where multiple organs-on-a-chip can be networked together to simulate the MC between organs.
Challenges and Opportunities
The application of MC (Molecular Communication) theory to human health in the aforementioned directions will face the following main challenges: 1) incomplete biological knowledge; 2) individuality and variations; 3) mutations and evolution; 4) safety and security; and 5) ethical concerns.
While this is not in the scope of this point-of-view paper, we recognize the importance of an upfront debate toward an ethical regulation of this research, as well as the future resulting technologies.
NO, YOU DON'T RECOGNIZE ANYTHING.
WHERE THE HECK ARE YOU TO STOP THIS?
THIS GUY IS JUST A PRETENDER SUCKING UP TAXPAYER MONEY FOR HIS GENOCIDAL PROFITEERING.
THESE ARE PHOTOS FROM HIS WEBSITES, AND AS WE ALL KNOW A PICTURE IS WORTH MORE THAN A THOUSAND WORDS:
HIS CURRENT ADDITIONAL AFFILIATIONS
United Nations, International Telecommunication Union, Geneva, Switzerland
ITU Journal on Future and Evolving Technologies (ITU J-FET)
Founding Editor-in-Chief
(2020 – Present)
thank you
.
I Don’t Mind
All Of The Tubes And Cables
Sticking Out Of The Vaccinated.
I Am Just Wondering
If I Can Hook Up Two Of Them Together
To Make A Lava Lamp.
Or Use A Monitor Between Them
To Play Pong.
.